1009PD - The identification of the AXL/Gas6 signalling axis as a key player of myelodysplastic syndrome (MDS) and the potential of the oral selective AXL inhibitor bemcentinib in the treatment of MDS
| Autor: | Medyouf, H., Tirado-Gonzalez, I., Mies, A., Nevmerzhitskaya, A., Kubasch, A.-S., Platzbecker, U. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|